Official Journal of Research Center for Gastroenterology and Liver Diseases

e-ISSN 1735-3408

p-ISSN 1735-143X

Citation data

OpenAlex

Works that cite this article, indexed by OpenAlex.

34 resultsUpdated October 23, 2026

← Back to article

Sofosbuvir and daclatasvir for the treatment of COVID-19 outpatients: a double-blind, randomized controlled trial

Journal of Antimicrobial Chemotherapy 76(3) (2020)

Fatemeh Roozbeh; Majid Saeedi; Reza Alizadeh‐Navaei; Akbar Hedayatizadeh‐Omran; Shahin Merat; Hannah Wentzel; Jacob Levi; Andrew Martin Hill; Amir Shamshirian

Systematic review with meta‐analysis: effectiveness and tolerability of interferon‐free direct‐acting antiviral regimens for chronic hepatitis C genotype 1 in routine clinical practice in Asia

Alimentary Pharmacology & Therapeutics 47(5) (2018)

Fanpu Ji; Bin Wei; Yee Hui Yeo; Eiichi Ogawa; Biyao Zou; Christopher Donald Stave; Z. Li; Shuangsuo Dang; Norihiro Furusyo; Ramsey C Cheung; Mindie H. Nguyen

An intervention to improve HCV testing, linkage to care, and treatment among people who use drugs in Tehran, Iran: The ENHANCE study

International Journal of Drug Policy 72 (2019)

Maryam Alavi; Hossein Poustchi; Shahin Merat; Soudeh Kaveh; Afarin Rahimi‐Movaghar; Behrang Shadloo; Behzad Hajarizadeh; Jason Grebely; Gregory J. Dore; Reza Malekzadeh

SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost, Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter, Phase III Clinical Trial

Clinical Infectious Diseases 70(10) (2019)

Shahin Merat; Shahin Merat; Amir‐Houshang Sharifi; Hossein Poustchi; Eskandar Hajiani; Abdolsamad Gharavi; Jalal Karimi; Fariborz Mansour‐Ghanaei; Mohammad Reza Fattahi; Lida Ahmadi; Mohammad Hossein Somi; Hamid Kalantari; Mohammad Reza Ghadir; Farshad Sheikhesmaeili; Nadieh Baniasadi; Masoudreza Sohrabi; Seyed Hamid Moosavy; Masood Ziaee; Mohammad Javad Zahedi; Marjan Mokhtare; Shahnaz Sali; Babak Sayad; Behrooz Afshar; Alireza Bakhshipour; Abazar Parsi; Afsaneh Sharifian; Taghi Amiriani; Zeinab Malekzadeh; Dorsa Merat; Azita Ganji; Fereidoun Rahmani Samani; Raika Jamali; Masoomeh Sofian; Mohammad Ghezlou; Amir Ali Sohrabpour; Ladan Goshayeshi; Seyed-Mohammad Valizadeh-Toosi; Layli Eslami; Iradj Maleki; Ahmad Hormati; Aliakbar Shayesteh; Elahe Shayesteh; Alireza Norouzi; Zahra Abna; Alireza Janbakhsh; Hafez Tirgar Fakheri; Mohammad Minakari; Hossein Sardarian; Adel F allah Ghajary; Mojtaba Fattahi Abdizadeh; Maryam Latifnia; Fatemeh Roozbeh; Shahram Agah; Saba Fakhrieh Asl; Alireza Nateghi-Baygi; Babak Fattahi; Helia Nateghi-Baygi; Andrew Martin Hill; Reza Malekzadeh

Effectiveness of generic direct-acting agents for the treatment of hepatitis C: systematic review and meta-analysis

Bulletin of the World Health Organization 98(3) (2019)

Hugo Perazzo; Rodolfo Castro; Paula M. Luz; Mariana Banholi; Rafaela Valentim Goldenzon; Sandra Wagner Cardoso; Beatriz Gilda Jegerhorn Grinsztejn; Valdilea Gonçalves Veloso

Drug use and risk behaviour profile, and the prevalence of HIV, hepatitis C and hepatitis B among people with methamphetamine use in Iran

International Journal of Drug Policy 73 (2019)

Ghobad Moradi; Behzad Hajarizadeh; Khaled Rahmani; Amjad Mohamadi-Bolbanabad; Sonia Darvishi; Bushra Zareie; Fatemeh Azimian Zavareh; Heidar Sharafi; Seyed Moayed Alavian; Rashid Ramazani; Mehrdad Eftekhar; Seyed Ramin Radfar; Bakhtiar Piroozi; Mohammad Mehdí Gouya

Performance of a rapid diagnostic test for screening of hepatitis C in a real-life prison setting

Journal of Clinical Virology 113 (2019)

Heidar Sharafi; Hossein Poustchi; Fatemeh Azimian Zavareh; Babak Tamadoni; Rashid Ramezani; Mohamad Mehdi Gouya; Mahdi Sheikh; Farnaz Hashemi; Mehrzad Tashakorian; Ramin Alasvand; Seyed Moayed Alavian; Shahin Merat

Systematic review and meta-analysis: real-world effectiveness of direct-acting antiviral therapies in chronic hepatitis C genotype 3 in Asia

BMJ Open Gastroenterology 5(1) (2018)

Bin Wei; Fanpu Ji; Yee Hui Yeo; Eiichi Ogawa; Christopher Donald Stave; Shuangsuo Dang; Zongfang Li; Norihiro Furusyo; Ramsey C Cheung; Mindie H. Nguyen

Update on Recommendations for the Clinical Management of Hepatitis C in Iran 2017

Hepatitis Monthly 17(11) (2017)

Seyed Moayed Alavian; Heidar Sharafi

Barriers and motivators to participation and retention in HIV/HCV cohort studies among people who inject drugs: a community consultation in Iran

Substance Abuse Treatment Prevention and Policy 15(1) (2020)

Ali Mirzazadeh; Samira Hosseini‐Hooshyar; Armita Shahesmaeili; Ali Bahramnejad; Adibeh Barshan; Ghazal Mousavian; Esmail Najafi; Hamid Pour Sharifi; Ali Akbar Haghdoost; Alya Briceño; Willi McFarland; Kimberly Page

Hepatitis C Virus Infection in Pregnancy and Children: Its Implications and Treatment Considerations with Directly Acting Antivirals: A Review

Journal of Nepal Medical Association 59(241) (2021)

Ramesh Rana; Rajkumar Dangal; Yogendra Prasad Singh; Ram Bahadur Gurung; Bhim Rai; Amit Kumar Sharma

Hepatitis C virus infection in Iran: A review of current prevalence and preventive strategies from a developing country

Journal of Clinical Virology Plus 4(3) (2024)

Marcarious Moorkereh Tantuoyir; Muhammed M. Camara; Marjan Sohrabi; SeyedAhmad SeyedAlinaghi; Zahra Ahmadinejad

A simple risk-based strategy for hepatitis C virus screening among incarcerated people in a low- to middle-income setting

Harm Reduction Journal 17(1) (2020)

Sanam Hariri; Maryam Sharafkhah; Maryam Alavi; Gholamreza Roshandel; Abdolreza Fazel; Taghi Amiriani; Nazgol Motamed-Gorji; Abolfazl Bazazan; Shahin Merat; Hossein Poustchi; Reza Malekzadeh

Generic Direct Acting Antiviral Treatment: The First Step Towards Elimination of Hepatitis C in Iran

Hepatitis Monthly 17(1) (2017)

Behzad Hajarizadeh

Treatment of hepatitis C virus infection with direct-acting antivirals plus ribavirin eliminates viral RNA from peripheral blood mononuclear cells and reduces virologic relapse in diverse hepatic parenchymal changes

Archives of Virology 166(4) (2021)

Mohamed Darwish Ahmed Abd Alla; Reham Mohammed Dawood; Hassan Abd EL-Hafeth Rashed; Galal Abd-Elhamid Abo Farrag; Islam Abdelmawla Emran Ammar; Mohamed Mahmoud Abdel-Halim Mahmoud; Ghada Maher Salum; Ahmed Mohamed Abdulhamid Altanbouly; Mai Abd El-Meguid; Mostafa K. El Awady

Changes in liver fibrosis in patients with chronic hepatitis C after successful direct‐acting antiviral therapy

International Journal of Clinical Practice 75(6) (2021)

Anahita Sadeghı; Roya Amiri; Elham Akbarpour; Babak Mirminachi; Amir‐Houshang Sharifi; Shahin Merat

Estimating the incidence rate of hepatitis B and C in East Azerbaijan, Islamic Republic of Iran

Eastern Mediterranean Health Journal 26(7) (2019)

Mohammad Hossein Somi; Simin Khayatzadeh; Mohammad Nalbandy; Shahnaz Naghashi; Zeinab Nikniaz

Single‐pill sofosbuvir and daclatasvir for treating hepatis C in patients co‐infected with human immunodeficiency virus

International Journal of Clinical Practice 75(8) (2021)

Seyed Ali Dehghan Manshadi; Shahin Merat; Minoo Mohraz; Mehrnaz Rasoolinejad; Shahnaz Sali; Masoud Mardani; Payam Tabarsi; Mohammad Hossein Somi; Roya Sedghi; Katayoun Tayeri; Mehri Nikbin; Jalal Karimi; Amir‐Houshang Sharifi; Saeed Kalantari; Alireza Norouzi; Dorsa Merat; Zeinab Malekzadeh; Babak Mirminachi; Hossein Poustchi; Reza Malekzadeh

Antiviral Drugs

Side effects of drugs annual (2018)

Sreekumar Othumpangat; John D. Noti

An intervention to increase hepatitis C virus diagnosis and treatment uptake among people in custody in Iran

International Journal of Drug Policy 95 (2021)

Sanam Hariri; Maryam Alavi; Gholamreza Roshandel; Zahra Mohammadi; Abdolreza Fazel; Taghi Amiriani; Abolfazl Bazazan; Nazgol Motamed-Gorji; Amir Ali Sohrabpour; Shahin Merat; Hossein Poustchi; Reza Malekzadeh

Efficacy of Direct Acting Antivirals (DAA) therapy in patients with recurrent hepatitis C after liver and kidney transplantation: a cross-sectional study

Frontiers in Medicine 11 (2024)

Mehdi Kashani; Mehdi Karimi; Alireza Sharifi Rayeni; Mohammad Ali Azizi Nadian; Masoud Mortezazadeh; Amirhossein Parsaei; Nooshin Abolghasemi; Niyousha Shirsalimi; Abbas Mofidi; Seyyed Taher Seyyed Mahmoudi

A rapid review of the epidemiology and combating strategies of hepatitis C virus infection in Ghana

Journal of Clinical Virology Plus 4(4) (2024)

Marcarious Moorkereh Tantuoyir; Muhammed M. Camara; Marjan Sohrabi; SeyedAhmad SeyedAlinaghi; Zahra Ahmadinejad

Treatment of hepatitis C virus infection with direct-acting antiviral agent-based regimens in Iranian patients with hereditary bleeding disorders

Virology Journal 18(1) (2021)

Heidar Sharafi; Bita Behnava; Alireza Azizi-saraji; Ali Namvar; Ali Anvar; Shima Salimi; Seyed Moayed Alavian

Effects of 12-week treatment with Sovodak in patients infected by genotype 1 hepatitis C virus

Journal of Analytical Research in Clinical Medicine 7(1) (2019)

Hosein Mehdipour; Seyed Yaghoub Moaddab; Khalil Azizian; Morteza Ghojazadeh; Mohammad Hossein Somi

Association of HCV genotype with viral load among Iranian blood donors: a penalized logistic regression

Medical Journal of the Islamic Republic of Iran 33 (2019)

Fahimeh Ranjbar Kermani; Sedigheh Amini‐Kafiabad; Kamran Mousavi Hosseini; Mahtab Maghsudlu; Zohreh Sharifi; Mohammad Alì Mansournia

Sofosbuvir and Ribavirin with or Without Pegylated-Interferon in Hepatitis C Virus Genotype-2 or -3 Infections: A Systematic Review and Meta-Analysis

Archives of Clinical Infectious Diseases In Press(In Press) (2019)

Mohammad Ehsan Bayatpoor; Mohammad Hossein Khosravi; Heidar Sharafi; Mohammad Saeid Rezaee Zavareh; Bita Behnava; Seyed Moayed Alavian

Efficacy of Sovodak in the Management of Patients Co-infected with HIV/HCV

Advanced Pharmaceutical Bulletin 10(4) (2020)

Mohammad Hossein Somi; Bita Sepehri; Zeinab Nikniaz; Roya Sedghi

EFFECTIVENESS AND SAFETY OF SOFOSBUVIR AND VELPATASVIR IN HEMODIALYSIS PATIENTS SUFFERING WITH HEPATITIS C INFECTION

Journal of University Medical & Dental College 12(1) (2021)

Yasir Mehmood; Muhammad Imran Ashraf; Khadija Mastoor; Adnan Afzal; Zafar Latif Awan

Erratum to: SD1000: High Sustained Viral Response Rate in 1361 Patients With Hepatitis C Genotypes 1, 2, 3, and 4 Using a Low-cost Fixed-dose Combination Tablet of Generic Sofosbuvir and Daclatasvir: A Multicenter Phase III Clinical Trial

Clinical Infectious Diseases 73(1) (2021)

Shahin Merat; Amir‐Houshang Sharifi; Hossein Poustchi; Eskandar Hajiani; Abdolsamad Gharavi; Jalal Karimi; Fariborz Mansour‐Ghanaei; Mohammad Reza Fattahi; Lida Ahmadi; Mohammad Hossein Somi; Hamid Kalantari; Mohammad Reza Ghadir; Farshad Sheikhesmaeili; Nadieh Baniasadi; Masoudreza Sohrabi; Seyed Hamid Moosavy; Masood Ziaee; Mohammad Javad Zahedi; Marjan Mokhtare; Shahnaz Sali; Babak Sayad; Behrooz Afshar; Alireza Bakhshipour; Abazar Parsi; Afsaneh Sharifian; Taghi Amiriani; Zeinab Malekzadeh; Dorsa Merat; Azita Ganji; Fereidoun Rahmani Samani; Raika Jamali; Masoomeh Sofian; Mohammad Ghezlou; Amir Ali Sohrabpour; Ladan Goshayeshi; Seyed-Mohammad Valizadeh-Toosi; Layli Eslami; Iradj Maleki; Ahmad Hormati; Aliakbar Shayesteh; Elahe Shayesteh; Alireza Norouzi; Zahra Abna; Alireza Janbakhsh; Hafez Tirgar Fakheri; Mohammad Minakari; Hossein Sardarian; Adel F allah Ghajary; Mojtaba Fattahi Abdizadeh; Maryam Latifnia; Fatemeh Roozbeh; Shahram Agah; Saba Fakhrieh Asl; Alireza Nateghi-Baygi; Babak Fattahi; Helia Nateghi-Baygi; Andrew Martin Hill; Reza Malekzadeh

Comments on “The Efficacy of 12 Weeks of Sofosbuvir, Daclatasvir, and Ribavirin in Treating Hepatitis C Patients with Cirrhosis, Genotypes 1 and 3”

Hepatitis Monthly 17(3) (2017)

Babak Sayad; Fatemeh Norooznezhad; Alireza Farokhi